Christer Rosen - 01 Jul 2025 Form 4 Insider Report for JUPITER NEUROSCIENCES, INC. (JUNS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Jul 2025, 14:53:00 UTC
Prior SEC filing
01 Jul 2025
Next SEC filing
04 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christer Rosen

Key filing fact

Christer Rosen filed Form 4 for JUPITER NEUROSCIENCES, INC. (JUNS) on 03 Jul 2025.

Key facts

  • This page summarizes Christer Rosen's Form 4 filing for JUPITER NEUROSCIENCES, INC. (JUNS).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Jul 2025, 14:53.

Change

  • Previous filing in this sequence was filed on 01 Jul 2025.
  • Current net transaction value: +$3,667.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000902453 Primary reporting owner

ROSEN CHRISTER

Relationship
CEO and Chairman, Director, 10%+ Owner
Address
C/O JUPITER NEUROSCIENCES, INC., 1001 NORTH US HYWAY 1, SUITE 504, JUPITER
Signature
/s/ Christer Rosen
Signature date
03 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JUNS transaction

Common Stock

Purchase

Transaction value
$505
Shares
+500
Change %
+0%
Price
$1.01
Shares after
11,075,792
Date
01 Jul 2025
Ownership
Direct
JUNS transaction

Common Stock

Purchase

Transaction value
$3,162
Shares
+3,100
Change %
+0.03%
Price
$1.02
Shares after
11,078,892
Date
01 Jul 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .